Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy

Survival rates of pediatric sarcoma patients stagnated during the last two decades, especially in adolescents and young adults (AYAs). Targeted therapies offer new options in refractory cases. Gene expression profiling provides a robust method to characterize the transcriptome of each patient’s tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Weidenbusch, Bushra, Richter, Günther H.S., Kesper, Marie Sophie, Guggemoos, Monika, Gall, Katja, Prexler, Carolin, Kazantsev, Ilya, Sipol, Alexandra, Lindner, Lars, Nathrath, Michaela, Witt, Olaf, Specht, Katja, Beitinger, Frigga, Knebel, Carolin, Hosie, Stuart, von Eisenhardt-Rothe, Rüdiger, Weichert, Wilko, Luettichau, Irene Teichert-von, Burdach, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945512/
https://www.ncbi.nlm.nih.gov/pubmed/29755686
http://dx.doi.org/10.18632/oncotarget.25087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945512/
https://www.ncbi.nlm.nih.gov/pubmed/29755686
http://dx.doi.org/10.18632/oncotarget.25087

Ejemplares similares